School of Biomedical Sciences, Charles Sturt University Wagga Wagga, NSW, Australia.
Ther Clin Risk Manag. 2005 Mar;1(1):33-8. doi: 10.2147/tcrm.1.1.33.53598.
Asthma is a chronic disease with both inflammatory and bronchoconstrictive elements and often requires multiple medications. Most asthma regimens include medications with different therapeutic modes of action and a number of different medication delivery devices. To effectively participate in their asthma management, patients need to recognize each of their medication types, understand their purpose, adhere to their treatment regimen, and be proficient in using the required delivery devices. This study evaluated patient knowledge of asthma pharmacotherapy and adherence. An interview study was undertaken in two rural locations, in Australia, to elicit participants' knowledge, use, and inhalation device technique. Of participants, 75.9% used preventer medication and the remaining 24.1% used reliever medication only. Of those using preventer medication, 82.5% could distinguish their preventer from a range of asthma medicines. Metered dose inhalers (MDIs) were used by 80% of participants; 23% used a Turbuhaler(R); 24% used an Accuhaler(R); and 5% used an MDI with a spacer device. The study established poor medication knowledge, suboptimal device technique, and disturbing levels of adherence with management recommendations. Asthma education strategies need to be modified to engage patients with low asthma knowledge to achieve improved patient outcomes. Further, strategies need to motivate patients to use preventer medication during times when they feel well.
哮喘是一种具有炎症和支气管收缩元素的慢性疾病,通常需要多种药物治疗。大多数哮喘治疗方案包括具有不同治疗模式的药物和许多不同的药物输送装置。为了有效地参与他们的哮喘管理,患者需要识别他们的每种药物类型,了解其用途,坚持他们的治疗方案,并熟练使用所需的输送装置。本研究评估了患者对哮喘药物治疗的认识和依从性。在澳大利亚的两个农村地区进行了一项访谈研究,以了解参与者的知识、使用和吸入装置技术。在使用预防药物的参与者中,75.9%使用预防药物,其余 24.1%仅使用缓解药物。在使用预防药物的参与者中,82.5%能够区分他们的预防药物和一系列哮喘药物。80%的参与者使用计量吸入器(MDI);23%使用 Turbuhaler(R);24%使用 Accuhaler(R);5%使用带间隔器的 MDI。该研究确定了药物知识差、装置技术不理想以及与管理建议的依从性差的问题。哮喘教育策略需要进行修改,以吸引哮喘知识水平低的患者,从而改善患者的治疗效果。此外,还需要采取策略来激励患者在感觉良好时使用预防药物。